Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker

Diffuse large B cell lymphoma (DLBCL) is a heterogeneous group of aggressive lymphomas that can be classified into three molecular subtypes by gene expression profiling (GEP): GCB, ABC and unclassified. Immunohistochemistry-based cell of origin (COO) classification, as a surrogate for GEP, using thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Batlle-López, Ana, de Villambrosía, Sonia González, Francisco, Mazorra, Malatxeberria, Sefora, Sáez, Anabel, Montalban, Carlos, Sánchez, Lydia, Garcia, Juan F., González-Barca, Eva, López-Hernández, Andrés, Ruiz-Marcellan, MC, Mollejo, Manuela, Grande, Carlos, Richards, Kristy L., Hsi, Eric D., Tzankov, Alexandar, Visco, Carlo, Xu-Monette, Zijun Y., Cao, Xin, Young, Ken H., Piris, Miguel Ángel, Conde, Eulogio, Montes-Moreno, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951269/
https://www.ncbi.nlm.nih.gov/pubmed/26910115
http://dx.doi.org/10.18632/oncotarget.7495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951269/
https://www.ncbi.nlm.nih.gov/pubmed/26910115
http://dx.doi.org/10.18632/oncotarget.7495

Ejemplares similares